Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating oral vadadustat for anemia of chronic kidney disease in patients naive to erythropoiesis-stimulating agents has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: WITHDRAWN